IP Library Granted Patent US 11,229,577
Granted Patent B2
US 11,229,577 · App. 16/331,554 · Granted Jan 25, 2022

Process for the manufacture of a solid pharmaceutical administration form

Inventors: Stefan Schiller (Darmstadt, DE); Andrea Hanefeld (Darmstadt, DE); Gerhard Jonschker (Heppenheim, DE)
Assignee: Merck Patent GmbH
A61J3/10A61K9/2095B29C64/165B29C64/209B33Y10/00B33Y80/00B29L2031/753B33Y30/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,229,577
App. No.
16/331,554
Granted
Jan 25, 2022
Kind
B2
Abstract

The present invention relates to a process for the preparation of a solid pharmaceutical administration form using a 3D printing process as well. The process is a printing process that allows the production of solid pharmaceutical administration forms in a flexible manner and in conformity with the high quality standards required for the production of pharmaceuticals.

Claims (23)

1. A process for the manufacture of a solid pharmaceutical administration form comprising an active ingredient comprising the steps

(a) spreading a powder comprising a fusible material and an active ingredient across a manufacturing area to create a powder bed;

(b) jet printing a fluid comprising an energy absorbing material onto the powder;

(c) irradiating the powder to induce heating of the energy absorbing material in the powder and thereby to induce melting and fusing of the fusible material present in the powder;

(d) spreading another layer of the powder onto the surface of unfused and fused powder and subsequently performing step (b) and step (c) again;

(e) optionally repeating step (d) as often as needed to build up the solid pharmaceutical administration form;

(f) separating the solid pharmaceutical administration form from the powder bed.

2. A process for the manufacture of a solid pharmaceutical administration form comprising an active ingredient comprising the steps

(a) spreading a powder comprising an active ingredient across a manufacturing area to create a powder bed;

(b) jet printing a fluid comprising a fusible material onto the powder;

(c) irradiating the powder to induce melting and fusing of the fusible material present in the powder;

(d) spreading another layer of the powder onto the surface of unfused and fused powder and subsequently performing step (b) and step (c) again;

(e) optionally repeating step (d) as often as needed to build up the solid pharmaceutical administration form;

(f) separating the solid pharmaceutical administration form from the powder bed.

3. A process for the manufacture of a solid pharmaceutical administration form according to claim 1 , wherein in step (b) a parting agent is jet printed onto the powder in parallel or subsequently to the jet printing of the energy absorbing material.

4. A process for the manufacture of a solid pharmaceutical administration form according to claim 1 , wherein pre-heating is applied in steps (a) and (d) prior to or after spreading the powder.

5. Process according to claim 1 , wherein a cooling step is introduced between steps (e) and (f).

6. Process according to claim 1 , wherein the irradiating is with irradiation energy that is infrared energy (IR), near-infrared energy (NIR), visible light (VIS), ultraviolet light (UV), microwave or X-radiation.

7. Process according to claim 1 , wherein in step (b) the fluid is jet printed more than once in parallel or subsequent jet printings.

8. Process according to claim 1 , wherein an active ingredient is jet printed in step (b) and wherein the powder used in steps (a) and (d) does not comprise an active ingredient.

9. Process according to claim 1 , characterized in that the powder used in step (a) of the process further comprises an inert material.

10. Process according to claim 1 , characterized in that the powder used in step (a) of the process further comprises an additional functional material.

11. Process according to claim 1 , wherein the irradiating is with irradiation energy that is infrared energy (IR).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2019
From: SCHILLER, STEFAN; HANEFELD, ANDREA; JONSCHKER, GERHARD
To: MERCK PATENT GMBH
Reel/Frame 048537/0930 →
Priority Claims (1)
EP 16188177 · Sep 9, 2016 · regional
Continuity (1)
Related Publication 20190192383A1 · Jun 27, 2019
Cited By (1)
US 12,569,447